Published in Proc Am Thorac Soc on May 01, 2008
The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest (2011) 2.14
New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol (2010) 1.49
IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One (2011) 1.37
Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc (2008) 1.31
Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.29
Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis (2010) 1.19
Influence of airway wall stiffness and parenchymal tethering on the dynamics of bronchoconstriction. Am J Physiol Lung Cell Mol Physiol (2010) 1.16
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res (2010) 1.10
CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res (2011) 1.07
Formation and repair of tobacco carcinogen-derived bulky DNA adducts. J Nucleic Acids (2010) 0.98
Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers. Diagn Pathol (2012) 0.96
Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in mice. Respir Res (2012) 0.94
Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem (2014) 0.93
Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats. Respir Res (2009) 0.92
Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS One (2014) 0.91
IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir Res (2013) 0.91
RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol (2012) 0.90
The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron (2011) 0.89
Ets homologous factor regulates pathways controlling response to injury in airway epithelial cells. Nucleic Acids Res (2014) 0.88
Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One (2012) 0.88
Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm (2010) 0.88
Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med Genet (2009) 0.88
Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res (2010) 0.87
Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer. Cancer Res (2011) 0.85
Association between HMGB1 and COPD: A Systematic Review. Mediators Inflamm (2015) 0.84
Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J Inflamm (Lond) (2012) 0.83
Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency. COPD (2009) 0.82
A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice. Respir Res (2009) 0.81
Glutathione S-transferase copy number variation alters lung gene expression. Eur Respir J (2011) 0.81
Changes of HMGB1 and sRAGE during the recovery of COPD exacerbation. J Thorac Dis (2014) 0.80
The mode of lymphoblastoid cell death in response to gas phase cigarette smoke is dose-dependent. Respir Res (2009) 0.78
Long-term effects of acupuncture treatment on airway smooth muscle in a rat model of smoke-induced chronic obstructive pulmonary disease. Acupunct Med (2015) 0.78
Airway wall thickness is increased in COPD patients with bronchodilator responsiveness. Respir Res (2014) 0.78
Scientific respiratory symposium, paris june 2010. J Asthma Allergy (2011) 0.77
Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease. BMC Pulm Med (2015) 0.77
Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers. PLoS One (2014) 0.77
Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. PLoS One (2016) 0.76
Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure. Int J Mol Sci (2017) 0.75
Recognizing occupational effects of diacetyl: What can we learn from this history? Toxicology (2016) 0.75
Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease. Int J Mol Med (2016) 0.75
Olfactory Receptors Modulate Physiological Processes in Human Airway Smooth Muscle Cells. Front Physiol (2016) 0.75
Tristetraprolin Down-Regulation Contributes to Persistent TNF-Alpha Expression Induced by Cigarette Smoke Extract through a Post-Transcriptional Mechanism. PLoS One (2016) 0.75
Postoperative apnea, respiratory strategies, and pathogenesis mechanisms: a review. J Anesth (2012) 0.75
Is osteoporosis an autoimmune mediated disorder? Bone Rep (2017) 0.75
Cigarette Smoke Increases CD8α(+) Dendritic Cells in an Ovalbumin-Induced Airway Inflammation. Front Immunol (2017) 0.75
Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema. Biochem Biophys Rep (2016) 0.75
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol (2007) 14.99
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med (2003) 14.60
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med (2007) 8.97
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax (1957) 6.64
IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev (2004) 4.78
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum (2004) 4.58
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax (2000) 4.45
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol (2001) 3.91
Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med (1974) 3.88
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.69
Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem (2003) 3.39
A pathological study of emphysema of the lungs with chronic bronchitis. Thorax (1958) 3.37
Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med (1996) 3.14
The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med (1978) 3.14
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 3.02
The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol (2006) 2.98
Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest (2000) 2.92
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Eur Respir J (1998) 2.51
Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.51
An animal model of autoimmune emphysema. Am J Respir Crit Care Med (2004) 2.40
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med (1995) 2.24
Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med (2004) 2.23
Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med (1996) 2.21
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.21
Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol (2002) 2.18
The macroscopic anatomy of pulmonary emphysema. Australas Ann Med (1956) 2.07
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol (1985) (1993) 2.01
Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.94
The incidence of pulmonary emphysema, with observations on the relative incidence and spatial distribution of various types of emphysema. Am Rev Respir Dis (1963) 1.92
Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med (2001) 1.88
Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2005) 1.85
Inflammatory cells in the airways in COPD. Thorax (2006) 1.79
Airway mucus: From production to secretion. Am J Respir Cell Mol Biol (2006) 1.73
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J (2001) 1.68
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax (2004) 1.57
Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J (1994) 1.54
Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J (1995) 1.52
Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest (1997) 1.52
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax (2002) 1.51
Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res (2005) 1.50
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis (1985) 1.45
Clinical relevance of airway remodelling in airway diseases. Eur Respir J (2007) 1.44
Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis (1990) 1.43
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med (2000) 1.40
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Cigarette smoking and health. American Thoracic Society. Am J Respir Crit Care Med (1996) 1.39
The stability of peripheral airways. Respir Physiol (1970) 1.37
Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol (2006) 1.31
Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. Am Rev Respir Dis (1985) 1.30
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax (2002) 1.26
The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J (1999) 1.25
Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. N Engl J Med (1998) 1.20
Contribution of emphysema and small airways in COPD. Chest (1996) 1.19
The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction. Am Rev Respir Dis (1985) 1.19
Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in Guinea pigs. Chest (2003) 1.16
Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med (1995) 1.14
Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med (2004) 1.12
Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc (2005) 1.08
High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med (2003) 1.08
The bronchiolar epithelium in cigarette smokers. Observations with the scanning electron microscope. Am Rev Respir Dis (1975) 1.07
CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. Am J Physiol Lung Cell Mol Physiol (2005) 1.06
Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs. Am Rev Respir Dis (1980) 1.02
The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.02
Relation between distal airspace size, bronchiolar attachments, and lung function. Thorax (1993) 1.01
Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration (2004) 1.00
Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. Am J Respir Crit Care Med (2004) 0.98
Ongoing airway inflammation in patients with COPD who Do not currently smoke Chest (2000) 0.96
Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstruction. Chest (2003) 0.96
Panlobular emphysema: anatomy and pathodynamics. Dis Chest (1962) 0.94
Radial traction and small airways disease in excised human lungs. Am Rev Respir Dis (1986) 0.89
Effect of cigarette smoking on structure of the small airways. Lung (1987) 0.88
Pathophysiology of the small airways. Semin Respir Crit Care Med (2003) 0.84
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
A randomized study of endobronchial valves for advanced emphysema. N Engl J Med (2010) 6.23
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA (2004) 3.07
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A (2005) 1.82
CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81
Treatment of persistent pulmonary air leaks using endobronchial valves. Chest (2009) 1.75
Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration (2014) 1.74
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68
Respiratory failure after lung transplantation. Chest (2003) 1.67
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Lung volume reduction therapies for advanced emphysema: an update. Chest (2010) 1.58
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A (2002) 1.55
Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet (2009) 1.52
Pulmonary diseases and the heart. Circulation (2007) 1.52
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology (2003) 1.51
Are chemokines the third major system in the brain? J Leukoc Biol (2005) 1.50
African Americans and men with severe COPD have a high prevalence of osteoporosis. COPD (2008) 1.49
Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg (2005) 1.46
Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol (2004) 1.45
Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med (2012) 1.43
Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient. J Heart Lung Transplant (2005) 1.42
Viewing chemokines as a third major system of communication in the brain. AAPS J (2006) 1.39
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med (2009) 1.36
Smoking patterns in African Americans and whites with advanced COPD. Chest (2004) 1.33
Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci U S A (2004) 1.32
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol (2003) 1.30
Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.29
Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol (2004) 1.27
Advanced emphysema in African-American and white patients: do differences exist? Chest (2006) 1.24
Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med (2005) 1.23
Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.21
Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol (2004) 1.20
Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood (2006) 1.19
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15
Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res (2014) 1.14
The molecular basis for neuroimmune receptor signaling. J Neuroimmune Pharmacol (2012) 1.11
Small airway pathology and bronchoreversibility in advanced emphysema. COPD (2010) 1.11
Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res (2010) 1.10
Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev (2002) 1.08
Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. J Interferon Cytokine Res (2005) 1.07
Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J Biol Chem (2003) 1.07
CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. Am J Physiol Lung Cell Mol Physiol (2005) 1.06
Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.04
Small airway mucous metaplasia and inflammation in chronic obstructive pulmonary disease. COPD (2008) 1.03
Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema--potential mechanisms, treatment algorithm, and case examples. Respiration (2014) 1.03
The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.02
Intralobar sequestration in the middle-aged and elderly adult: recognition and radiographic evaluation. J Thorac Cardiovasc Surg (2003) 1.02
Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study. Chest (2006) 1.02
The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest (2004) 0.99
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 0.99
Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B). AIDS Res Hum Retroviruses (2007) 0.99
Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend (2006) 0.99
Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J Neuroimmunol (2008) 0.99
Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. Am J Respir Crit Care Med (2004) 0.98
The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med (2015) 0.98
Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res (2009) 0.98
Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 0.97
Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B). J Acquir Immune Defic Syndr (2002) 0.97
Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med (2007) 0.96
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med (2011) 0.96
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 0.96
Exercise testing in severe emphysema: association with quality of life and lung function. COPD (2008) 0.96
Tiotropium bromide for chronic obstructive pulmonary disease. Expert Rev Respir Med (2009) 0.96
Preventing acute exacerbations and hospital admissions in COPD. Chest (2013) 0.95
Pathogenesis of inflammation and repair in advanced COPD. Semin Respir Crit Care Med (2010) 0.94
Regulation of mu opioid receptor expression in developing T cells. J Neuroimmune Pharmacol (2012) 0.93
The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs. Virology (2002) 0.93
Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol (2002) 0.93
Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 0.91
NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol (2006) 0.91
Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest (2005) 0.90
The small airways in chronic obstructive pulmonary disease: pathology and effects on disease progression and survival. Curr Opin Pulm Med (2013) 0.89
Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. Am J Respir Crit Care Med (2014) 0.89
Complications of long-term mechanical ventilation. Respir Care Clin N Am (2002) 0.89
DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-beta1. J Leukoc Biol (2008) 0.89
Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation. Eur Respir J (2012) 0.89
Pulmonary tumor embolism. Lung (2010) 0.88
Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules. J Neuroimmunol (2003) 0.88
Full face mask for noninvasive positive-pressure ventilation in patients with acute respiratory failure. J Am Osteopath Assoc (2007) 0.87
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis (2012) 0.86
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD (2013) 0.86
High incidence of venous thromboembolic events in lung transplant recipients. J Heart Lung Transplant (2007) 0.85
Total lung capacity by plethysmography and high-resolution computed tomography in COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.85
Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc (2015) 0.85
Cardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2006) 0.84
Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation. COPD (2011) 0.84
Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids. COPD (2012) 0.83
Chronic cough and dyspnea in ice hockey players after an acute exposure to combustion products of a faulty ice resurfacer. Lung (2007) 0.83